Cardiac Signs Good for New Diabetes Drug

EASD 2012 — BERLIN — An investigational agent for type 2 diabetes was generally well tolerated in patients at high risk of heart disease, although data on specific cardiovascular outcomes have not yet been released, researchers reported here.


< Back to Listings